The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human
- Conditions
- Acute LeukemiaCMV ViremiaHematopoietic Stem Cell Transplantation
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04298502
- Locations
- 🇨🇳
Peking University Institute of Hematology, Beijing, Beijing, China
Detection of Lung Cancer by Plasma Lipids
Completed
- Conditions
- Early-Stage Lung Cancer
- Interventions
- Diagnostic Test: Plasma lipids
- First Posted Date
- 2020-02-27
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 558
- Registration Number
- NCT04287712
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Apatinib for Inoperable Advanced Chondrosarcoma
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04260113
- Locations
- 🇨🇳
Musculoskeletal Tumor Center of Peking University People's Hospital, Beijing, Beijing, China
🇨🇳Peking Univresity Shougang Hospital, Beijing, Beijing, China
Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy
Phase 2
- Conditions
- Inflammatory Myopathy
- Interventions
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04237987
Establishment and Validation of Early-warning Model of Perioperative Pain for the Elders
- Conditions
- Pain AssessmentElderlyModelPostoperative Pain
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 6000
- Registration Number
- NCT04228705
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Next Generation Pathogen Sequencing for Prediction of Infection in Rheumatic Disease
- Conditions
- Infection
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04226261
Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT04225780
NK Cell Infusion for Patients With Acute Myeloid Leukemia
Phase 1
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Drug: chemotherapy combined with NK cells infusion
- First Posted Date
- 2020-01-09
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT04221971
- Locations
- 🇨🇳
Peking University Institute of Hematology, Beijing, Beijing, China
The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT04217148
- Locations
- 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia
- Conditions
- Corticosteroid-resistant or Relapsed ITP
- Interventions
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04214951
- Locations
- 🇨🇳
Peking University Institute of Hematology, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath